Galen Growth | Redefining Digital Health Intelligence

🌍 Did digital health funding stall in Q2 2025? 👇 Drop a “INSIGHT” in the comments and hit follow to receive the full report in your inbox! We analyzed thousands of companies and market shifts across North America, Europe, APAC and the Middle East. 📊 The Galen Growth Q2 2025 State of Digital Health Report is here. #DigitalHealth #HealthTech #HealthcareInnovation #DigitalHealthFunding

Here’s where the momentum (and money) in digital health is. 👇 Drop a “INSIGHT” in the comments and hit follow to receive the full analysis in your inbox! We analyzed thousands of companies and market shifts across North America, Europe, APAC and the Middle East. 📊 The Galen Growth Q2 2025 State of Digital Health Report is here. #DigitalHealth #HealthTech #HealthcareInnovation #DigitalHealthFunding

🔍 The Digital Health Exit Landscape in 2025: #Consolidation, #Discipline, and Selective #Momentum #H12025 marked a critical #turningpoint for the #digitalhealth #ecosystem. With #IPOs still tentative and M&A activity accelerating, the first half of the year confirmed what many have sensed: the #hype has #faded, and #outcomes now matter more than ever. 📉 #Global #exits reached 113 in #H1, including only 6 IPOs — but standout #debuts from Hinge Health and Omada Health showed that #public markets still #reward strong #fundamentals and #clinical #validation. 🤝 M&A continues to dominate, fuelled by roll-up #strategies, distressed #valuations, and #AI-driven transformation — 70% of all #deals were #venture-to-venture (#V2V). 🧠 #Investors are doubling down on AI-powered, #productivity-focused #solutions, and the #secondarymarket is stepping up as a critical #liquidity path. #Read the full Galen Growth | Redefining Digital Health Intelligence deep dive on #exits, #funding, and #investor #sentiment in #H12025 — and discover why the year ahead demands greater focus, smarter bets, and the right data. 📊 #Insights powered by #HealthTechAlpha, the leading #GenAI-powered platform for digital health #intelligence.

Everyone’s talking about digital health’s Q2 pivot. This is where they’re getting the data. 👇 Drop a “INSIGHT” in the comments and hit follow to receive the full analysis in your inbox! We analyzed thousands of companies and market shifts across North America, Europe, APAC and the Middle East. 📊 The Galen Growth Q2 2025 State of Digital Health Report is here. #DigitalHealth #HealthTech #HealthcareInnovation #DigitalHealthFunding

How different is digital health now compared to last year? The data’s in! 👇 Drop a “INSIGHT” in the comments and hit follow to receive the full analysis in your inbox! We analyzed thousands of companies and market shifts across North America, Europe, APAC and the Middle East. 📊 The Galen Growth Q2 2025 State of Digital Health Report is here. #DigitalHealth #HealthTech #HealthcareInnovation #DigitalHealthFunding

Is digital health changing course in 2025? Q2 holds the clues. 👇 Drop a “INSIGHT” in the comments and hit follow to receive the full analysis in your inbox! We analyzed thousands of companies and market shifts across North America, Europe, APAC and the Middle East. 📊 The Galen Growth Q2 2025 State of Digital Health Report is here. #DigitalHealth #HealthTech #HealthcareInnovation #DigitalHealthFunding

There’s been a lot of HealthTech M&A activity in recent days. This shows that the HealthTech sector is maturing, with the first winners and losers starting to emerge, and larger healthcare platforms being built that could challenge incumbents. This post was made possible thanks to data from HealthTech Alpha by Galen Growth | Redefining Digital Health Intelligence. I’ve written down a few extra thoughts. 1️⃣ 𝐌𝐨𝐬𝐭 𝐌&𝐀 𝐝𝐞𝐚𝐥𝐬 𝐡𝐚𝐯𝐞 𝐛𝐞𝐞𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒 Even European private equity firms like Nordic Capital are choosing to invest in US companies such as Arcadia. Yet there are many smaller “Arcadias” in Europe as well. These M&A deals happening in the US will likely start happening in Europe soon. 2️⃣ 𝐋𝐞𝐬𝐬 𝐭𝐡𝐚𝐧 𝟏𝟎% 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡𝐓𝐞𝐜𝐡 𝐢𝐬 𝐚𝐝𝐝𝐫𝐞𝐬𝐬𝐚𝐛𝐥𝐞 𝐛𝐲 𝐏𝐄 𝐭𝐨𝐝𝐚𝐲... 𝐚𝐧𝐝 𝟑𝟎% 𝐢𝐧 𝟓 𝐲𝐞𝐚𝐫𝐬, 𝟖𝟎% 𝐢𝐧 𝟏𝟎 𝐲𝐞𝐚𝐫𝐬? From various discussions, my gut feeling is that less than 10% of HealthTech is currently suitable for mid-cap and large-cap private equity. Mid-cap private equity firms usually look for companies with at least €30M in revenue and 20% EBIT. That excludes more than 90% of HealthTech companies today. 3️⃣ 𝐒𝐚𝐦𝐬𝐮𝐧𝐠: 𝐬𝐞𝐫𝐢𝐨𝐮𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐓𝐞𝐜𝐡 𝐧𝐞𝐰𝐜𝐨𝐦𝐞𝐫 𝐨𝐫 𝐭𝐨𝐨 𝐥𝐚𝐭𝐞 𝐭𝐨 𝐭𝐡𝐞 𝐩𝐚𝐫𝐭𝐲? By acquiring Xealth, Samsung confirms its ambitions in HealthTech. So far, no Big Tech company has truly managed to disrupt healthcare, despite bold claims five years ago. Apple, which comes closest to Samsung in this space, has been especially disappointing in healthcare over the last two years. Will Samsung learn from Apple’s mistakes and find a winning strategy? 4️⃣ 𝐄𝐮𝐫𝐨𝐩𝐞 𝐧𝐞𝐞𝐝𝐬 𝐦𝐨𝐫𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐓𝐞𝐜𝐡 𝐌&𝐀 Many local HealthTech companies in Europe have reached single-digit ARR and (almost) profitability. On average, it took them 5 to 10 years to get there. To reach double-digit ARR, these local companies may need to merge with their peers in other European countries to build European champions. This is what happened in the US. For example, Memora was acquired by Commure, and Lumeon was acquired by Health Catalyst to help them scale. ------ Follow HGM Advisory for daily reposts of the most important #HealthTech news. If you are a #healthcare investor, make sure that you join the Healthcare Business International conference in March 2026 in Paris. (the leading Private Equity x Healthcare innovation conference in Europe). #mergers #acquisitions #privateequity

Why is so much Digital Health funding flowing into Health Management and TechBio solutions right now? 👇 Drop a “INSIGHT” in the comments and hit follow to receive the full analysis in your inbox! We analyzed thousands of companies and market shifts across North America, Europe, APAC and the Middle East. 📊 The Galen Growth Q2 2025 State of Digital Health Report is here. #DigitalHealth #HealthTech #HealthcareInnovation #DigitalHealthFunding

Discover cutting-edge digital solutions for healthcare with HealthTech Alpha’s Products Hub. Try it now: https://lnkd.in/dhWirrXW #DigitalHealth #HealthTech #DataPlatform #MarketResearch

The best insights come from experience 💭 If digital technology innovation in healthcare is your jam, you’ll want to hear Julien de Salaberry on stage in Barcelona. As a CEO & Founder of Galen Growth | Redefining Digital Health Intelligence, he carries unparalleled expertise in delivering cutting-edge research, analytics, and insights to industry leaders and investors. Hear what he has to say: https://lnkd.in/dDjuC4m6